Nouvelles & Évènements
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
Leveraging her scientific knowledge and entrepreneurial mindset, Dr. Karla Williams is developing a blood test that could allow for early diagnosis of aggressive breast cancer.
GlycoNet awards $1.45 million to eight projects aimed at improving the health of Canadians. Funding supports glycomics translational research into post-surgical pain management, cancer diagnosis, and treatment of Parkinson’s disease, infectious diseases and chronic illness.
By Ali Chou “We need to encourage girls and women to be confident; […] we need to support their growth, enthusiasm, and their participation in …
Canadian researchers and Taiwanese institution break boundaries to advance glycomics research by Ali Chou GlycoNet Investigators giving lectures at Short Courses in Frontier Science and …
Network investigators and trainees will receive communications support to promote their research and its positive impact by GlycoNet Staff The Canadian Glycomics Network (GlycoNet) recently …
he Canadian research ecosystem works for the well-being of all Canadians. It is founded on multidisciplinary and translational innovation and fuelled by partnerships between a vibrant university research sector and industry.Politicians have long understood that a national alignment of research priorities helps find concrete solutions to the current and future needs of Canadians. Cross-country research collaboration also allows all provinces, including Alberta, to attract and retain talent and to diversify their economy.
GlycoNet investigator Matthew Macauley awarded major grant from the Canadian Institutes of Health Research
By Marie-Christine Houle As Canadian Alzheimer’s Awareness Month wraps up, we shed some light on the work of Matthew Macauley, a GlycoNet investigator and professor …
Keeping the gut microbiota, the micro-organisms living in our intestines, in balance is important in preventing disease.A GlycoNet-funded project is looking at using glycans (sugars) to restore an imbalance that occurs in patients suffering from inflammatory bowel disease (IBD).